TC Biopharm (Holdings) Plc
TCBPY
$0.28
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -48.21% | 34.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 1,480.00% | -- | |||
| Total Operating Expenses | -39.56% | 7.29% | |||
| Operating Income | 39.56% | -7.29% | |||
| Income Before Tax | 39.36% | -5.40% | |||
| Income Tax Expenses | 4.99% | 41.84% | |||
| Earnings from Continuing Operations | 40.51% | -8.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.51% | -8.33% | |||
| EBIT | 39.56% | -7.29% | |||
| EBITDA | 40.86% | -8.09% | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | -- | |||
| Average Diluted Shares Outstanding | -- | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||